title: Nitazoxanide versus metronidazole for Clostridium difficile-associated colitis.
authors.forename: Jeremy D
authors.initials: JD
authors.lastname: Young
authors.forename: Julie E
authors.initials: JE
authors.lastname: Mangino
authors.forename: Kurt B
authors.initials: KB
authors.lastname: Stevenson
authors.forename: Susan L
authors.initials: SL
authors.lastname: Koletar
mesh_terms: D000368:Aged; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016360:Clostridioides difficile / Q000187:drug effects*; D006224:Cricetinae; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use*; D009574:Nitro Compounds; D013844:Thiazoles / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D009574:Nitro Compounds; D013844:Thiazoles; D008795:Metronidazole; C041747:nitazoxanide